Solid Biosciences Inc (SLDB)
8.91
-0.39
(-4.19%)
USD |
NASDAQ |
May 17, 15:47
Solid Biosciences Cash from Operations (Quarterly): -20.82M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -20.82M |
| September 30, 2023 | -17.90M |
| June 30, 2023 | -27.46M |
| March 31, 2023 | -28.00M |
| December 31, 2022 | -34.48M |
| September 30, 2022 | -20.43M |
| June 30, 2022 | -15.88M |
| March 31, 2022 | -27.19M |
| December 31, 2021 | -20.87M |
| September 30, 2021 | -18.42M |
| June 30, 2021 | -17.10M |
| March 31, 2021 | -21.37M |
| December 31, 2020 | 1.307M |
| September 30, 2020 | -15.56M |
| Date | Value |
|---|---|
| June 30, 2020 | -13.07M |
| March 31, 2020 | -29.27M |
| December 31, 2019 | -21.24M |
| September 30, 2019 | -19.24M |
| June 30, 2019 | -26.30M |
| March 31, 2019 | -25.93M |
| December 31, 2018 | -21.40M |
| September 30, 2018 | -15.29M |
| June 30, 2018 | -16.33M |
| March 31, 2018 | -17.17M |
| December 31, 2017 | -13.98M |
| September 30, 2017 | -9.439M |
| June 30, 2017 | -9.607M |
| March 31, 2017 | -10.20M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-34.48M
Minimum
Dec 2022
1.307M
Maximum
Dec 2020
-20.70M
Average
-20.82M
Median
Dec 2023
Cash from Operations (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | -242.08M |
| PTC Therapeutics Inc | 70.76M |
| Capricor Therapeutics Inc | -1.268M |
| Catalyst Pharmaceuticals Inc | 31.92M |
| Pfizer Inc | 1.09B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 45.30M |
| Cash from Financing (Quarterly) | 0.505M |
| Free Cash Flow | -95.70M |
| Free Cash Flow Per Share (Quarterly) | -1.034 |
| Free Cash Flow Yield | -54.02% |